Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022;20(6):457-462.
doi: 10.2174/1570162X20666220624100248.

SARS-CoV-2/COVID-19: Clinical Course Among Subjects HIV-1-Infected in Sao Paulo

Mariana A Monteiro  1 , Gabriela S Prates  1 , Najara A de Lima Nascimento  1 , Ana Paula R Veiga  1 , Marcello M C Magri  1 , Thales J B Polis  1 , Maria R P Gascon  1 , Mauricio D Ferreira  1 , Larissa Tiberto  1 , Luisa O Pereira  1 , Wagner Alves  1 , Luiz A M Fonseca  1 , Alberto J S Duarte  1 , Jorge Casseb  1
Affiliations

SARS-CoV-2/COVID-19: Clinical Course Among Subjects HIV-1-Infected in Sao Paulo

Mariana A Monteiro et al. Curr HIV Res. 2022.

Abstract

Introduction: People living with Human Immunodeficiency Virus (HIV) are under risk for co-infection with SARS-CoV-2. This population may be more prone to complications from COVID-19 due to persistent inflammation caused by HIV and higher incidence of metabolic syndromes, cardiovascular diseases, and malignancies, as well as being considered elderly at 50 years of age. The objective of this study was to report SARS-CoV-2 infection frequency, clinical evolution, and mortality in HIV-positive patients on antiretroviral therapy.

Methods: The period of inquiry ranged from January to September 2020. Due to the social distance and the suspension of in-person medical care during the time of the investigation, we sent electronic questions about demographic, epidemiological, and clinical data to 403 HIV-infected patients.

Results: Among 260 patients who answered the questionnaire, thirty-nine patients (15%) had suggestive symptoms and were tested for SARS-CoV-2 infection. Of this, 11 had positive results (32.4%) and no patient died of COVID-19 complications. Nine were male (3.4%), and the mean age of the patients with positive results was 43.2 years (± 9.6). 107 patients (41.1%) were over 50 years of age and their mean T-CD4+ cell count was 768. Eleven patients (4.2%) had a detectable HIV RNA viral load and 127 (48.8%) had comorbidities. These variables were not associated with an increased risk for infection.

Conclusion: The frequency of SARS-COV2 infection among HIV-infected is similar to the general population, and the clinical course is associated with the presence of comorbidities and not due to the HIV infection. However, new studies should be done to assess if this vulnerable population could answer the vaccine anti-SARS-Cov2.

Keywords: COVID-19; HIV; SARS-CoV-2; cytokines; hypoxia; lymphocytopenia..

PubMed Disclaimer

References

    1. Li C.; Romagnani P.; Von Brunn A.; Anders H.J.; SARS-CoV-2 and Europe: Timing of containment measures for outbreak control. Infection 2020,48(3),483-486 - DOI - PubMed
    1. Jin Y.; Yang H.; Ji W.; Virology, epidemiology, pathogenesis, and control of COVID-19. Viruses 2020,12(4),E372 - DOI - PubMed
    1. Johns hopkins coronavirus resource center COVID-19 MapDisponível em: 2022. Availble: 2022
    1. Castillo C.; Villalobos Dintrans P.; Maddaleno M.; The successful COVID-19 vaccine rollout in Chile: Factors and challenges. Vaccine X 2021,9,100114 - DOI - PubMed
    1. Umakanthan S.; Sahu P.; Ranade A.V.; Origin, transmission, diagnosis and management of coronavirus disease 2019 (COVID-19). Postgrad Med J 2020,96(1142),753-758 - PubMed

Publication types